University of California-San Francisco · Biomedical EngineeringFlavell Theranostics Lab
Robert Richard Flavell · San Francisco, California
Research Focus
Dr. Robert Flavell's lab focuses on developing innovative therapies for cancers, specifically targeting CD46 in multiple myeloma and prostate cancer. The research aims to optimize radioimmunotherapy methods that minimize side effects while effectively treating tumors. The lab combines various scientific disciplines, including chemistry, biology, and imaging, to advance cancer treatment strategies and enhance diagnostic methods.
CD46radioimmunotherapymultiple myelomaprostate cancertheranostics
Research Aims
3AIM 01Develop novel CD46 targeting therapeutic agents for multiple myeloma.
AIM 02Optimize CD46 directed radioimmunotherapy for prostate cancer treatment.
AIM 03Systematically test the efficacy and toxicity of new therapies in metastatic cancer models.
Skills the Lab Values
radiochemistryPET imagingantibody-drug conjugatesanimal modelinghistologydosimetry analysismetabolomicsclinical trial designdata analysispreclinical studies
Output against the department
Publications463top 18% of dept.109th of 595
this lab
most publishedleast published
Citations4.5kbottom 34% of dept.390th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.